Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion

[1] Porcel JM(2014)Etiology of pleural effusions: analysis of more than 3000 consecutive thoracenteses Arch Bronconeumol 50 161-165

[2] Esquerda A(2015)Clinical features and survival of lung cancer patients with pleural effusions Respirology 20 654-659

[3] Vives M(1987)Positive effusion cytology as the initial presentation of malignancy Acta Cytol 31 448-452

[4] Bielsa S(1988)The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis Acta Cytol 32 183-187

[5] Porcel JM(2008)Pleurésies malignes révélatrices d’un cancer: comparaison des étiologies avec les pleurésies métastatiques d’un cancer connu Rev Mal Respir 25 1104-1109

[6] Gasol A(2015)Predictors of clinical use of pleurodesis and/or indwelling pleural catheter therapy for malignant pleural effusion Chest 147 1629-1634

[7] Bielsa S(2014)Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score Thorax 69 1098-1104

[8] Civit C(2017)Examination of cytological smears and cell blocks of pleural fluid: complementary diagnostic value for malignant effusions Rev Clin Esp 217 144-148

[9] Light RW(undefined)undefined undefined undefined undefined-undefined

[10] Salud A(undefined)undefined undefined undefined undefined-undefined

[1] Porcel JM(2014)Etiology of pleural effusions: analysis of more than 3000 consecutive thoracenteses Arch Bronconeumol 50 161-165

[2] Esquerda A(2015)Clinical features and survival of lung cancer patients with pleural effusions Respirology 20 654-659

[3] Vives M(1987)Positive effusion cytology as the initial presentation of malignancy Acta Cytol 31 448-452

[4] Bielsa S(1988)The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis Acta Cytol 32 183-187

[5] Porcel JM(2008)Pleurésies malignes révélatrices d’un cancer: comparaison des étiologies avec les pleurésies métastatiques d’un cancer connu Rev Mal Respir 25 1104-1109

[6] Gasol A(2015)Predictors of clinical use of pleurodesis and/or indwelling pleural catheter therapy for malignant pleural effusion Chest 147 1629-1634

[7] Bielsa S(2014)Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score Thorax 69 1098-1104

[8] Civit C(2017)Examination of cytological smears and cell blocks of pleural fluid: complementary diagnostic value for malignant effusions Rev Clin Esp 217 144-148

[9] Light RW(undefined)undefined undefined undefined undefined-undefined

[10] Salud A(undefined)undefined undefined undefined undefined-undefined